SIFI > International Markets
International Markets
In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding into international markets.

Internationalization for SIFI Group means exporting a brand that is synonymous with specialization and tradition in ophthalmology, quality and innovation, ethics and professionalism, scientific education and proximity to physicians and patients, high medical and technological contents and commitment to social responsibility.

SIFI group has acquired a strong presence in the Americas and in European countries, either through its own subsidiaries or through partnering commercial distributors.

Currently the global key markets include Mexico, Romania, Spain, UK, Russia and Turkey where SIFI already has a significant presence through exclusive distributors.

Direct subsidiaries are present in Mexico (Laboratorios SIFI de México S.A. de C.V.) and Romania (Oftafarma srl).

share & tag us with
#EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
#Development
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
International Markets In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding...
 
Quality We CARE for patients; all patients, even those frequently left behind by the industry, such as individuals afflicted by rare diseases.   SIFI’s 80-year long history is distinguished...
 
Code of Ethics SIFI SpA SIFI S.p.A. (Hereinafter also referred to as SIFI or the Company) has adopted ethical and behavioural principles that are consistent with the guidelines established...

On our Social Channels

From our News Center

SIFI, the Italian leader in the development of therapeutic solutions to treat ophthalmic disorders and global pharmaceutical major, Zydus Cadila, have tied up to market innovative IOLs (Intraocular...
 

 

15 May

DIABETIC MACULAR EDEMA New therapeutic perspectives and integrated management: patient quality of life and opportunities for the National Health Service (SSR) Diabetic...
Follow Us!